Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers
Clinical trial NCT04804254 · TERMINATED
Trial details
- NCT number
- NCT04804254
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2023-01-11
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.